Ikarian Capital, LLC Options Holdings

Ikarian Capital, LLC

  • $328 Million
  • Q2 2025

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
RARE
Ultragenyx Pharmaceutical Inc.

Healthcare
CALL
$20.5 Million
563K
Q2 2025
Added 200.0%
CAPR
Capricor Therapeutics, Inc.

Healthcare
PUT
$13.5 Million
1.36M
Q2 2025
New holding
RARE
Ultragenyx Pharmaceutical Inc.

Healthcare
PUT
$10.9 Million
300K
Q2 2025
Added 200.0%
VKTX
Viking Therapeutics, Inc.

Healthcare
CALL
$9.28 Million
350K
Q2 2025
Added 133.33%
MLTX
Moon Lake Immunotherapeutics

Healthcare
PUT
$9.18 Million
195K
Q2 2025
Added 105.82%
CAPR
Capricor Therapeutics, Inc.

Healthcare
CALL
$6.95 Million
700K
Q2 2025
New holding
SRPT
Sarepta Therapeutics, Inc.

Healthcare
CALL
$5.68 Million
332K
Q2 2025
New holding
CYTK
Cytokinetics Inc

Healthcare
CALL
$4.96 Million
150K
Q2 2025
New holding
KALV
Kal Vista Pharmaceuticals, Inc.

Healthcare
CALL
$4.52 Million
400K
Q2 2025
New holding
MLTX
Moon Lake Immunotherapeutics

Healthcare
CALL
$4.46 Million
94.5K
Q2 2025
Added 105.82%
VERA
Vera Therapeutics, Inc.

Healthcare
CALL
$3.61 Million
153K
Q2 2025
New holding
SRRK
Scholar Rock Holding Corp

Healthcare
CALL
$3.54 Million
100K
Q1 2025
Reduced 2.06%
TEVA
Teva Pharmaceutical Industries LTD

Healthcare
CALL
$3.35 Million
200K
Q1 2025
Added 100.0%
ALT
Altimmune, Inc.

Healthcare
CALL
$3.2 Million
828K
Q2 2025
New holding
CNTA
Centessa Pharmaceuticals PLC

Healthcare
CALL
$2.63 Million
200K
Q2 2025
New holding
AKRO
Akero Therapeutics, Inc.

Healthcare
CALL
$2.37 Million
44.4K
Q2 2025
New holding
COGT
Cogent Biosciences, Inc.

Healthcare
CALL
$1.89 Million
263K
Q2 2025
New holding
PRTA
Prothena Corp Public LTD CO

Healthcare
CALL
$607,000
100K
Q1 2025
New holding
KYMR
Kymera Therapeutics, Inc.

Healthcare
PUT
$436,000
10K
Q2 2025
Reduced 94.34%
PCVX
Vaxcyte, Inc.

Healthcare
CALL
$224,000
6.9K
Q2 2025
New holding
Biohaven LTD
CALL
$0
300K
Q2 2025
New holding
Cidara Therapeutics Inc
PUT
$0
502K
Q2 2025
New holding
Uniqure Nv
CALL
$0
800K
Q2 2025
New holding
Cidara Therapeutics Inc
CALL
$0
321K
Q2 2025
New holding
Apogee Therapeutics Inc
CALL
$0
8.4K
Q2 2025
Added 11.88%
Apogee Therapeutics Inc
PUT
$0
79.1K
Q2 2025
Added 11.88%
Soleno Therapeutics Inc
PUT
$0
200K
Q2 2025
Added 100.0%
Soleno Therapeutics Inc
CALL
$0
200K
Q2 2025
Added 100.0%
Praxis Precision Medicines I
CALL
$0
242K
Q2 2025
New holding

Summary

  • Portfolio
  • No. of Stocks 133
  • Current Value $328 Million
  • Prior Value $714 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 24 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 28 stocks
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email